Dentsply International | XRAY - Ebitda

Aktienkurs
11.91
Täglich Wechseln
0.01 0.08%
Monatlich
1.97%
Jährlich
-13.38%
Q2 Prognose
11.66




Ebitda Veränderung Datum
3M USD 1.41B 267M 2025-12
Agilent USD 540M 74M 2025-09
Align Technology USD 183.84M 19.77M 2025-09
Bruker USD 211.6M 207.4M 2025-12
Cardinal Health USD 981M 5M 2025-12
Charles River Laboratories USD 258.06M 24.83M 2025-12
Cooper Companies USD 323.4M 13.2M 2025-12
CVS Health USD 3.74B 349M 2025-12
Danaher USD 1.92B 204M 2026-03
Dentsply International USD 135M 32M 2025-12
Henry Schein USD 291M 4M 2025-12
Idexx Laboratories USD 391.47M 17.97M 2025-09
Illumina USD 332M 12M 2025-09
Integra LifeSciences USD 104.21M 25.76M 2025-12
Intuitive Surgical USD 1.09B 165.5M 2025-12
IQVIA Holdings USD 1.05B 97M 2025-12
McKesson USD 1.68B 418M 2025-09
Medtronic USD 2.93B 482M 2025-12
Mettler Toledo International USD 322.64M 26.75M 2025-09
Owens Minor USD 90.02M 2.15M 2025-12
Repligen USD 39.54M 3.61M 2025-12
Revvity USD 248.91M 48.52M 2025-12
Smith & Nephew USD 796M 139M 2025-12
Stryker USD 1.67B 206M 2025-09
Thermo Fisher Scientific USD 2.7B 464M 2026-03
Veradigm USD 38.81M 29.61M 2022-09
Waters USD 380.97M 85.83M 2025-12
Zimmer Biomet Holdings USD 759M 120.8M 2025-12
Zoetis USD 1.04B 87M 2025-09